Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent [Phase 3]
Phase 3 results for guselkumab in active psoriatic arthritis patients who had inadequate response or intolerance to one prior anti-TNF agent…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent [Phase 3]
Phase 3 trial update evaluating guselkumab in active psoriatic arthritis patients with inadequate response/intolerance to one prior anti-TNF…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
A post-marketing safety study in Denmark evaluated abatacept (Orencia) for rheumatoid arthritis and psoriatic arthritis; the study has compl…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register
A post-marketing safety study of abatacept in Sweden using the SRQ register has completed, evaluating safety in rheumatoid arthritis and pso…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons
A clinical trial sponsored by Odense University Hospital studying immune-competent cell manifestations in the Achilles tendons of patients w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases [Phase 2]
Phase 2 trial evaluating the safety and efficacy of an oral capsule fecal microbiota transplant (FMT) in treatment-naïve patients with newly…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA [Phase 3]
Phase 3 trial comparing golimumab plus methotrexate against methotrexate alone in very early psoriatic arthritis; results have been posted.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis [Phase 4]
Phase 4 clinical trial update assessing GLP-1 receptor agonists in non-diabetic patients with psoriatic arthritis; recruitment is not yet st…
-
FDA approval · 2025-12-01FDA Approved: SELARSDI — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for SELARSDI (USTEKINUMAB-AEKN), a biosimilar to ustekinumab.
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: 2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis
A completed two-year real-world study assessing retention, quality of life, effectiveness and treatment patterns of secukinumab in adults wi…
-
EMA approval · 2025-12-01EMA Authorised: Benepali (etanercept) — Samsung Bioepis NL B.V.
The European Medicines Agency authorised Benepali (etanercept), a biosimilar to etanercept, for inflammatory conditions including rheumatoid…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Improving Virtual Care of Arthritis: Integrating a Smartphone App Into the EHR for Improved Timeliness of Visits [NA]
This clinical trial update describes integrating a smartphone app with the electronic health record to improve timeliness of virtual visits …
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial [Phase 4]
The SPEED trial, a Phase 4 study of early intervention to control disease in severe psoriatic arthritis, has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Effect of Metformin on Carotid Atherosclerosis for Non-diabetic Patients With PsA (CAMPA Study) [Phase 4]
Phase 4 trial evaluating whether metformin affects carotid atherosclerosis in non-diabetic patients with psoriatic arthritis; the CAMPA stud…
-
EMA approval · 2025-11-21EMA Authorised: Usgena (ustekinumab) — Stada Arzneimittel AG
The European Medicines Agency authorised Usgena, a ustekinumab product from STADA, for treatment of Crohn's disease, psoriasis, psoriatic ar…
-
EMA approval · 2025-11-21EMA Authorised: Pyzchiva (ustekinumab) — Samsung Bioepis NL B.V.
EMA authorised Pyzchiva (ustekinumab) for Crohn's disease, ulcerative colitis, and psoriatic arthritis.
-
FDA approval · 2025-11-20FDA Approved: IMULDOSA — Supplemental Application (Accord BioPharma Inc.)
FDA approved a supplemental application for IMULDOSA (USTEKINUMAB-SRLF) from Accord BioPharma Inc. The action updates the regulatory status …
-
EMA approval · 2025-11-20EMA Authorised: Gobivaz (golimumab) — Advanz Pharma Limited
The EMA authorised Gobivaz (golimumab) for multiple inflammatory diseases. Indications include rheumatoid arthritis, juvenile idiopathic art…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis [Phase 1]
Phase 1 clinical trial assessing the safety and pharmacokinetics of LPX-TI641 in patients with rheumatoid arthritis and psoriatic arthritis,…
-
FDA approval · 2025-11-19FDA Approved: SELARSDI — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for SELARSDI (ustekinumab-aeKn) from Teva Pharmaceuticals USA, Inc. The product is a ustekinumab bio…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: The Effect of Ketogenic Diet Versus Mediterranean Diet in Patients With Obesity and Psoriatic Arthritis [NA]
Completed clinical trial comparing ketogenic diet to Mediterranean diet in adults with obesity and psoriatic arthritis; the available snippe…
-
FDA approval · 2025-11-18FDA Approved: USTEKINUMAB-TTWE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for USTEKINUMAB-TTWE from Quallent Pharmaceuticals Health LLC.
-
EMA approval · 2025-11-10EMA Authorised: Flixabi (infliximab) — Samsung Bioepis NL B.V.
The EMA authorised Flixabi, a biosimilar of infliximab, for several inflammatory diseases. The indications include rheumatoid arthritis, pso…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
A clinical trial is evaluating an educational tool to help melanoma patients with pre-existing autoimmune diseases who are candidates for im…
-
FDA approval · 2025-11-03FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for Ustekinumab (Stelara) from Janssen Biotech, Inc., related to regulatory changes to its label…